Kevin Holden

Head of Science at Synthego
Kevin Holden is Head of Science at Synthego in Redwood City, California. He is a senior member of a research team responsible for integrating CRISPR genome engineering workflows into novel automation platforms. In addition, he oversees academic and industrial collaborations with key opinion leaders in the CRISPR community, and leads interactions with the company’s scientific advisors. He has over 10 years of biotechnology experience that includes collaborative research in synthetic biology and genome engineering. Kevin earned his PhD in Microbiology from The University of California, Davis.


November 8 2019, 08:00
 - 09:30
Discussion Workshop And Breakfast: The Advancement Of CRISPR In Discovery And Therapeutic Development
November 8 2019, 12:00
 - 12:30
New Technologies For Enhancing The Efficiency Of CRISPR-Based Cell Engineering At Scale

Live Webinar

Higher Quality Nucleic Acid Extraction from FFPE Tissue & Other Challenging Samples Using the Ionic™ Purification System

hosted by Klint Rose, Chief Scientific Officer, Purigen Biosystems

Wednesday 27th May
16:00 BST